There are increasing policy and market drivers for removing chemicals of concern from manufacturing processes and products. These drivers have centered primarily on developed countries.
The purpose of this study was to examine how innovative SDP organizations’ interactions with external stakeholders influence the social innovation process.

The number of countries with a national development plan has more than doubled, from about 62 in 2006 to 134 in 2018.

Elsevier,

Antimicrobial Resistance, 2019. 

This article selection displays a sample of research that Elsevier publishes in its microbiology and medical journals, highlighting Elsevier's contribution to the efforts of battling the huge problem of antimicrobial resistance (AMR). Research within this selection supports SDGs 3 (good health and well-being), 6 (clean water and sanitation), 12 (responsible production and consumption) and 17 (partnerships for the goals).
Elsevier, Progress in Disaster Science, Volume 2, July 2019
The Sendai Framework for Disaster Risk Reduction encourages investment in innovation and technology development in disaster risk management.
The UN has adopted the Sendai Framework for Disaster Risk Reduction (2015–2030; SFDRR) in March 2015 and the member countries agreed to shift from disaster management to disaster risk management.

The “build back better” (BBB) approach to disaster recovery was first introduced in 2006 by the United Nations Secretary-General's Special Envoy for Tsunami Recovery, former US President William Cl

This book chapter advances SDGs 3 and 17 by reviewing the neurochemical aspects of Alzheimer’s type of Dementia.
Elsevier,

Biomarkers in Toxicology, Second Edition, 2019, Pages 885-894

This chapter advances the UN SDG goal 3 and 17 by discussing the etiology, disease mechanisms, and biomarkers of Alzheimer's disease.
This book chapter advances SDGs 3 and 17 by focusing primarily on the recent developments in Alzheimer's Disease diagnosis and their merits and demerits, including development of blood and cerebrospinal fluid–based biomarkers, imaging tools such as MRI, fMRI, and PET, proteomics, etc.

Pages